Dana E. Angelini, MD

Cleveland Clinic Foundation
Department of Hematology and Medical Oncology, Taussig Cancer Institute
Taussig Cancer Institute
Cleveland, OH
USA 44195
1237 Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism
3570 Deaths Due to Thrombotic Versus Bleeding Events within 90 Days of Cancer Associated Thrombosis
4809 Clinical Outcomes of Isolated Distal Deep Vein Thrombosis Associated with Cancer: The Cleveland Clinic Experience